Cancer Research Articles

Florida Cancer Specialists and Research Institute participation in clinical trials leads to FDA approval of polatuzumab vedotin.

A panel of multidisciplinary experts have reviewed previous American Society of Clinical Oncology (ASCO) guidelines for treating anxiety and depression in adult cancer survivors. The Practice Guidelines Implementation Network (PGIN) committee, which includes Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist Barry Berman, MD, MS, released updates to the pre-existing guidelines last revised in 2014 in the abstract: “Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update.”

Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist Richard McDonough, MD, is the recipient of the Florida Society of Clinical Oncology (FLASCO) 2023 Dorothy Green Phillips Legacy Award. The recognition was announced at FLASCO’s Annual Gala held on April 14 in Orlando.

Worldwide, many people start their day with a pick-me-up. Coffee and tea are the most common choices. In the United States, coffee is the hands-down favorite. Two-thirds of Americans drink it every day, totaling around 517 million cups every day! Worldwide consumption is 2 billion daily cups. Demand is predicted to triple by mid-century.

New study on myelosuppression from chemo for small cell lung cancer.

FCS members envision the next 20 years of community oncology care at 2023 COA conference.

Pharmacy experts and leaders from Florida Cancer Specialists & Research Institute (FCS) will join with colleagues this week to share the latest advances in oncology pharmacy operations and dispensing practices at the  NCODA 2023 Spring Forum in Indianapolis.

A television commercial produced by Florida Cancer Specialists & Research Institute, LLC (FCS) has been recognized with a Silver ADDY® by the American Advertising Awards, which honors excellence in advertising as judged by creative industry professionals around the world.